Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Upper airway function and non-intubated, assisted ventilation].

M Ohi1, K Chin, M Hirai

  • 1Department of Clinical Physiology, Chest Disease Research Institute, Kyoto University, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Chest negative pressure ventilation (CNPV) and nasal intermittent positive pressure ventilation (nIPPV) effectiveness depends on upper airway patency. Maintaining an open airway is crucial for optimal ventilation support in patients with chronic respiratory failure.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

ESMO gastrointestinal oncology·2026
Same author

BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer.

ESMO gastrointestinal oncology·2026
Same author

The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy.

ESMO gastrointestinal oncology·2026
Same author

Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma.

ESMO gastrointestinal oncology·2026
Same author

Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination.

ESMO gastrointestinal oncology·2026
Same author

Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice.

ESMO gastrointestinal oncology·2026

Area of Science:

  • Respiratory Physiology
  • Critical Care Medicine